Tuesday, December 1, 2015

Pfizer’s Deal for Allergan Is a Dubious Milestone by ROB COX


By ROB COX

That this high-water mark is justified by its tax workaround is a sign that the two-year boom of extraordinary corporate deals is reaching its conclusion.

Published: December 2, 2015 at 12:00AM

from NYT Business Day http://ift.tt/1Xw0le5



from WordPress http://ift.tt/1TsqGE3
via Hadi Aboukhater

No comments:

Post a Comment